Anacor Pharmaceuticals, Inc.

Anacor Pharmaceuticals, Inc.

Anacor Pharmaceuticals, Inc.

Overview
Date Founded

2000

Headquarters

235 East 42nd Street,New York, NY 10017

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA.

Contact Data
Trying to get in touch with decision makers at Anacor Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Vice President, Finance & Controller

Senior Vice President of Program Management

Senior Vice President, Drug Development

Vice President, Business Development

Chief Executive Officer

Investor

Head of Discovery Biology

Senior Director, Professional Relations

Senior Director

Board of Directors

Executive Chairman at NGM Biopharmaceuticals, Inc.

Former Executive Director of Discovery Research at Upjohn Pharmaceuticals Ltd.

Senior Vice President, Corporate Secretary & Chief Governance Counsel at Pfizer, Inc.

President at Encysive Pharmaceuticals, Inc.

In-House Counsel at Pfizer, Inc.

Paths to Anacor Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Anacor Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Pfizer, Inc. purchases Anacor Pharmaceuticals, Inc.

Details Hidden

Anacor Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Anacor Pharmaceuticals, Inc. issued USD Common Stock

Transaction Advisors
Underwriter

Advised onAnacor Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onAnacor Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onAnacor Pharmaceuticals, Inc. issued USD Common Stock

Counsel

Advised onPfizer, Inc. purchases Anacor Pharmaceuticals, Inc.

Head, Executive Compensation Group

Advised onPfizer, Inc. purchases Anacor Pharmaceuticals, Inc.

Legal Advisor

Advised onPfizer, Inc. purchases Anacor Pharmaceuticals, Inc.

Advisors & Consultants
Consultant

Executive Vice President, Chief Operating & Financial Officer at Tricida, Inc.

Legal Advisor

Senior Counsel at Davis Polk & Wardwell LLP

Clients

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Key Stats and Financials As of
Market Capitalization
$4.5B
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

Red Abbey Venture Partners is an active manager which invests in life science companies located in North America and Europe. The firm participates in early, late stage and PIPE transactions.

Details Hidden

Rho Ventures invests in companies located in the US. The firm targets companies operating in the fields of communications, healthcare and information technology. They provide financing for early and expansion stage capital requirements

Details Hidden

Investor at Fluidigm Corp.

Suppliers
Hovione Farmaciência SA Wholesale: Consumer Non-Durables/Sundries | Loures, Portugal

Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

Bausch Health Cos., Inc. Pharmaceuticals - Laval, Canada

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Anacor Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Anacor Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Anacor Pharmaceuticals, Inc..